139 related articles for article (PubMed ID: 29934723)
1. A COL1A1 Promoter-Controlled Expression of TGF-β Soluble Receptor Inhibits Hepatic Fibrosis Without Triggering Autoimmune Responses.
Zhang S; Gong Y; Xiao J; Chai Y; Lei J; Huang H; Xiang T; Shen W
Dig Dis Sci; 2018 Oct; 63(10):2662-2672. PubMed ID: 29934723
[TBL] [Abstract][Full Text] [Related]
2. Modulation of renal glomerular disease using remote delivery of adenoviral-encoded solubletype II TGF-beta receptor fusion molecule.
Haviv YS; Takayama K; Nagi PA; Tousson A; Cook W; Wang M; Lam JT; Naito S; Lei X; Carey DE; Curiel DT
J Gene Med; 2003 Oct; 5(10):839-851. PubMed ID: 14533192
[TBL] [Abstract][Full Text] [Related]
3. Blockage of transforming growth factor beta receptors prevents progression of pig serum-induced rat liver fibrosis.
Jiang W; Yang CQ; Liu WB; Wang YQ; He BM; Wang JY
World J Gastroenterol; 2004 Jun; 10(11):1634-8. PubMed ID: 15162539
[TBL] [Abstract][Full Text] [Related]
4. The antifibrotic effects of TGF-β1 siRNA on hepatic fibrosis in rats.
Lang Q; Liu Q; Xu N; Qian KL; Qi JH; Sun YC; Xiao L; Shi XF
Biochem Biophys Res Commun; 2011 Jun; 409(3):448-53. PubMed ID: 21600192
[TBL] [Abstract][Full Text] [Related]
5. [Construction and validation of a dual-luciferase reporter gene system for screening and evaluating anti-liver fibrosis drugs that inhibit transcription of the gene encoding collagen I, chain a1].
Zhang W; Dai X; Yu H; Wang L; Sun S; Li J; Zhou Y
Zhonghua Gan Zang Bing Za Zhi; 2014 Oct; 22(10):747-51. PubMed ID: 25496864
[TBL] [Abstract][Full Text] [Related]
6. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
7. Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure.
Okada H; Takemura G; Kosai K; Li Y; Takahashi T; Esaki M; Yuge K; Miyata S; Maruyama R; Mikami A; Minatoguchi S; Fujiwara T; Fujiwara H
Circulation; 2005 May; 111(19):2430-7. PubMed ID: 15867170
[TBL] [Abstract][Full Text] [Related]
8. [Effects of blocking two sites of transforming growth factor-β/Smads signaling on the formation of scar-related proteins in human skin fibroblasts].
Wang Y; Zhang L; Lei R; Shen Y; Shen H; Wu Z; Xu J
Zhonghua Shao Shang Za Zhi; 2015 Oct; 31(5):372-7. PubMed ID: 26714407
[TBL] [Abstract][Full Text] [Related]
9. Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro.
Tao YY; Wang QL; Shen L; Fu WW; Liu CH
Exp Biol Med (Maywood); 2013 Nov; 238(11):1284-96. PubMed ID: 24006304
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
[TBL] [Abstract][Full Text] [Related]
11. [Establishment of a reporter system for estimating activation of human hepatic stellate cells based on
Wang L; Jin XS; Dong HJ; Ou GM; Lai XY; Zhuang H; Li T; Xiang KH
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):876-885. PubMed ID: 37807743
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.
Russo LM; del Re E; Brown D; Lin HY
Diabetes; 2007 Feb; 56(2):380-8. PubMed ID: 17259382
[TBL] [Abstract][Full Text] [Related]
13. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor β1 induces the expression of collagen type I by DNA methylation in cardiac fibroblasts.
Pan X; Chen Z; Huang R; Yao Y; Ma G
PLoS One; 2013; 8(4):e60335. PubMed ID: 23560091
[TBL] [Abstract][Full Text] [Related]
15. Activation of TGF-β1-CD147 positive feedback loop in hepatic stellate cells promotes liver fibrosis.
Li HY; Ju D; Zhang DW; Li H; Kong LM; Guo Y; Li C; Wang XL; Chen ZN; Bian H
Sci Rep; 2015 Nov; 5():16552. PubMed ID: 26559755
[TBL] [Abstract][Full Text] [Related]
16. Effect of Function-Enhanced Mesenchymal Stem Cells Infected With Decorin-Expressing Adenovirus on Hepatic Fibrosis.
Jang YO; Cho MY; Yun CO; Baik SK; Park KS; Cha SK; Chang SJ; Kim MY; Lim YL; Kwon SO
Stem Cells Transl Med; 2016 Sep; 5(9):1247-56. PubMed ID: 27365486
[TBL] [Abstract][Full Text] [Related]
17. A Targeted Multiple Antigenic Peptide Vaccine Augments the Immune Response to Self TGF-β1 and Suppresses Ongoing Hepatic Fibrosis.
Li Y; Wang W; Jia X; Zhai S; Wang X; Wang Y; Dang S
Arch Immunol Ther Exp (Warsz); 2015 Aug; 63(4):305-15. PubMed ID: 25740471
[TBL] [Abstract][Full Text] [Related]
18. [Establishment and application of a high-throughput drug screening model based on COL1A1 promoter for anti-liver fibrosis].
Zhao SS; Wang JX; Wang YC; Shao RG; He HW
Yao Xue Xue Bao; 2015 Feb; 50(2):169-73. PubMed ID: 25975023
[TBL] [Abstract][Full Text] [Related]
19. Intracellular sphingosine 1-phosphate contributes to collagen expression of hepatic myofibroblasts in human liver fibrosis independent of its receptors.
Xiu L; Chang N; Yang L; Liu X; Yang L; Ge J; Li L
Am J Pathol; 2015 Feb; 185(2):387-98. PubMed ID: 25432063
[TBL] [Abstract][Full Text] [Related]
20. Effects of pentoxifylline on the hepatic content of TGF-beta1 and collagen in Schistosomiasis japonica mice with liver fibrosis.
Xiong LJ; Zhu JF; Luo DD; Zen LL; Cai SQ
World J Gastroenterol; 2003 Jan; 9(1):152-4. PubMed ID: 12508372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
